guest ::
| Home > Publications database > Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. > print |
| Home > Publications database > Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. > print |
| 001 | 186214 | ||
| 005 | 20240229145735.0 | ||
| 024 | 7 | _ | |a 10.1038/s41416-022-02071-3 |2 doi |
| 024 | 7 | _ | |a pmid:36460776 |2 pmid |
| 024 | 7 | _ | |a 0007-0920 |2 ISSN |
| 024 | 7 | _ | |a 1532-1827 |2 ISSN |
| 024 | 7 | _ | |a altmetric:139617422 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-03011 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Sedlmeier, Anja M |b 0 |
| 245 | _ | _ | |a Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. |
| 260 | _ | _ | |a Edinburgh |c 2023 |b Nature Publ. Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1677235116_26854 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2023 Feb;128(4):594-605 |
| 520 | _ | _ | |a Classical anthropometric traits may fail to fully represent the relationship of weight, adiposity, and height with cancer risk. We investigated the associations of body shape phenotypes with the risk of overall and site-specific cancers.We derived four distinct body shape phenotypes from principal component (PC) analysis on height, weight, body mass index (BMI), waist (WC) and hip circumferences (HC), and waist-to-hip ratio (WHR). The study included 340,152 men and women from 9 European countries, aged mostly 35-65 years at recruitment (1990-2000) in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards regression was used to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs).After a median follow-up of 15.3 years, 47,110 incident cancer cases were recorded. PC1 (overall adiposity) was positively associated with the risk of overall cancer, with a HR per 1 standard deviation (SD) increment equal to 1.07 (95% confidence interval 1.05 to 1.08). Positive associations were observed with 10 cancer types, with HRs (per 1 SD) ranging from 1.36 (1.30-1.42) for endometrial cancer to 1.08 (1.03-1.13) for rectal cancer. PC2 (tall stature with low WHR) was positively associated with the risk of overall cancer (1.03; 1.02-1.04) and five cancer types which were not associated with PC1. PC3 (tall stature with high WHR) was positively associated with the risk of overall cancer (1.04; 1.03-1.05) and 12 cancer types. PC4 (high BMI and weight with low WC and HC) was not associated with overall risk of cancer (1.00; 0.99-1.01).In this multi-national study, distinct body shape phenotypes were positively associated with the incidence of 17 different cancers and overall cancer. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Viallon, Vivian |b 1 |
| 700 | 1 | _ | |a Ferrari, Pietro |0 0000-0001-9358-7338 |b 2 |
| 700 | 1 | _ | |a Peruchet-Noray, Laia |b 3 |
| 700 | 1 | _ | |a Fontvieille, Emma |b 4 |
| 700 | 1 | _ | |a Amadou, Amina |b 5 |
| 700 | 1 | _ | |a Seyed Khoei, Nazlisadat |0 0000-0001-6003-7794 |b 6 |
| 700 | 1 | _ | |a Weber, Andrea |b 7 |
| 700 | 1 | _ | |a Baurecht, Hansjörg |b 8 |
| 700 | 1 | _ | |a Heath, Alicia K |0 0000-0001-6517-1300 |b 9 |
| 700 | 1 | _ | |a Tsilidis, Kostas |0 0000-0002-8452-8472 |b 10 |
| 700 | 1 | _ | |a Kaaks, Rudolf |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |b 11 |u dkfz |
| 700 | 1 | _ | |a Katzke, Verena |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 12 |u dkfz |
| 700 | 1 | _ | |a Inan-Eroglu, Elif |b 13 |
| 700 | 1 | _ | |a Schulze, Matthias B |b 14 |
| 700 | 1 | _ | |a Overvad, Kim |b 15 |
| 700 | 1 | _ | |a Bonet, Catalina |b 16 |
| 700 | 1 | _ | |a Ubago-Guisado, Esther |b 17 |
| 700 | 1 | _ | |a Chirlaque, María-Dolores |b 18 |
| 700 | 1 | _ | |a Ardanaz, Eva |b 19 |
| 700 | 1 | _ | |a Perez-Cornago, Aurora |0 0000-0002-5652-356X |b 20 |
| 700 | 1 | _ | |a Pala, Valeria |0 0000-0001-5438-970X |b 21 |
| 700 | 1 | _ | |a Tumino, Rosario |0 0000-0003-2666-414X |b 22 |
| 700 | 1 | _ | |a Sacerdote, Carlotta |b 23 |
| 700 | 1 | _ | |a Pasanisi, Fabrizio |b 24 |
| 700 | 1 | _ | |a Borch, Kristin B |0 0000-0002-1741-2322 |b 25 |
| 700 | 1 | _ | |a Rylander, Charlotta |b 26 |
| 700 | 1 | _ | |a Weiderpass, Elisabete |0 0000-0003-2237-0128 |b 27 |
| 700 | 1 | _ | |a Gunter, Marc J |b 28 |
| 700 | 1 | _ | |a Fervers, Béatrice |b 29 |
| 700 | 1 | _ | |a Leitzmann, Michael F |b 30 |
| 700 | 1 | _ | |a Freisling, Heinz |0 0000-0001-8648-4998 |b 31 |
| 773 | _ | _ | |a 10.1038/s41416-022-02071-3 |0 PERI:(DE-600)2002452-6 |n 4 |p 594-605 |t British journal of cancer |v 128 |y 2023 |x 0007-0920 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:186214 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2022-11-15 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-15 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-15 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-15 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-22 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRIT J CANCER : 2022 |d 2023-10-22 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-22 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-22 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b BRIT J CANCER : 2022 |d 2023-10-22 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|